<DOC>
	<DOCNO>NCT02810951</DOCNO>
	<brief_summary>The purpose study evaluate safety FCX-007 , evaluate C7 expression presence anchor fibril result FCX-007 analyze wound heal result FCX-007 administration subject RDEB .</brief_summary>
	<brief_title>A Study FCX-007 Recessive Dystrophic Epidermolysis Bullosa ( RDEB )</brief_title>
	<detailed_description>RDEB congenital progressive orphan skin disease cause deficiency protein type VII collagen ( COL7 ) . The objective study evaluate safety FCX-007 intradermal injection RDEB subject . Additionally , trial evaluate type VII collagen expression , presence anchor fibril result FCX-007 , well evidence wound heal . Six adult subject expect treated FCX-007 Phase I portion trial six subject age 7 old Phase II portion trial . All subject receive FCX-007 one pair target RDEB wound . Proof mechanism monitor digital photography target wound assay conduct biopsy take target wound .</detailed_description>
	<mesh_term>Epidermolysis Bullosa</mesh_term>
	<mesh_term>Epidermolysis Bullosa Dystrophica</mesh_term>
	<criteria>1 . Age 1 . Phase I ( subject 1 6 ) : Eighteen ( 18 ) year older . 2 . Phase II ( subject 7 12 ) : Seven ( 7 ) year older . 2 . Diagnosis recessive dystrophic epidermolysis bullosa ( RDEB ) 3 . NC1/NC2 Status ( test unknown ) 4 . Subjects , , opinion Investigator , able understand study , cooperate study procedure willing return clinic require followup visit 1 . Medical instability limit ability travel investigative center . 2 . Active infection HIV , hepatitis B hepatitis C 3 . A positive study specific immunofluorescence result 4 . Evidence systemic infection 5 . Current evidence metastatic squamous cell carcinoma site inject 6 . Known allergy constituent product 7 . Active drug alcohol addiction 8 . Hypersensitivity type anesthesia choose 9 . Receipt chemical biological study product specific treatment RDEB past six month 10 . Women pregnant breastfeed 11 . Abnormal clinically significant laboratory result 12 . Clinically significant abnormality NCI toxicity scale</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>RDEB</keyword>
</DOC>